非产物依赖型髓过氧化物酶荧光探针的开发及应用研究
结题报告
批准号:
22007012
项目类别:
青年科学基金项目
资助金额:
24.0 万元
负责人:
魏鹏
依托单位:
学科分类:
生物体系分子探针
结题年份:
2023
批准年份:
2020
项目状态:
已结题
项目参与者:
魏鹏
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
客服二维码
微信扫码咨询
中文摘要
髓过氧化物酶(MPO)是生物体内与炎症直接相关的含血红素的过氧化物酶,其异常表达与多种疾病的发生发展关系密切。因此,在生物体系中对MPO进行识别和示踪,对于明确MPO与特定疾病的关系,及早采取诊疗措施,避免疾病的进一步发展恶化具有重要意义。但包括当前已经商用的MPO检测试剂盒在内,各种以荧光作为信号输出的MPO检测体系都是反应产物依赖型的,不能直接识别MPO,因而检测的精确度有限,并且不适用于对MPO的原位识别。针对这一问题,本项目拟选择萘酰亚胺作为荧光团,利用MPO抑制剂4-氨基苯甲酰肼(ABAH)作为识别基团,构建基于PET机理的非产物依赖型MPO有机小分子荧光探针。并利用所构建探针在体液、细胞、活体三个层次进行应用。本项目将首次尝试构建以荧光作为信号输出的非产物依赖型MPO荧光探针,以实现MPO的精确检测,为构建MPO体外检测试剂盒,在细胞、活体层次探索MPO的生理功能提供分子工具。
英文摘要
Myeloperoxidase (MPO) is a heme-containing peroxidase that is directly related to inflammation in living organisms and the abnormal expression of MPO is closely related to the development of various diseases. Therefore, the identification and tracing of MPO in biological systems is of great significance for clarifying the relationship between MPO and specific diseases, taking treatment measures to avoid further development of the disease. However, the reported various MPO detection methods based on fluorescence imaging (including the currently commercially available MPO fluorescence detection kits) are reaction product-dependent, which could not identify MPO directly and is not suitable for MPO in-situ identification.To solve this problem, we intend to select naphthimide as the fluorophore and use MPO inhibitor 4-aminobenzohydrazide (ABAH) as the recognition group to construct product-independent MPO organic small molecule fluorescent probes based on PET mechanism in this work. And the probes constructed will be applied in vitro and in vivo. The development of this project will fill the current gaps in the absence of product-independent MPO fluorescent probes, and provide new tools for constructing MPO in vitro detection kits, exploring the physiological functions of MPO in vitro and in vivo.
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
DOI:10.1016/j.trac.2023.117461
发表时间:2023-11
期刊:TrAC Trends in Analytical Chemistry
影响因子:--
作者:Zhiting Wu;Yu Guo;Weiwei Jiang;Yuqin Yang;Peng Wei;Tao Yi
通讯作者:Zhiting Wu;Yu Guo;Weiwei Jiang;Yuqin Yang;Peng Wei;Tao Yi
Activated aggregation strategies to construct size‐increasing nanoparticles for cancer therapy
激活聚集策略来构建用于癌症治疗的尺寸增大的纳米颗粒
DOI:10.1002/wnan.1848
发表时间:2022
期刊:WIREs Nanomed Nanobiotechnol.
影响因子:--
作者:Zhenni Lu;Dongya Liu;Peng Wei;Tao Yi
通讯作者:Tao Yi
DOI:10.1002/advs.202303981
发表时间:2024-01-15
期刊:ADVANCED SCIENCE
影响因子:15.1
作者:Wang,Ben;Lu,Zhen-Ni;Dong,Jian
通讯作者:Dong,Jian
From fluorescent probes to the theranostics platform
从荧光探针到治疗诊断平台
DOI:10.1002/cjoc.202200122
发表时间:2022-05
期刊:Chin. J. Chem.
影响因子:--
作者:Peng Wei;Qing Wang;Tao Yi
通讯作者:Tao Yi
A Smart Theranostic Prodrug System Activated by Reactive Oxygen Species for Regional Chemotherapy of Metastatic Cancer
由活性氧激活的智能治疗前药系统,用于转移性癌症的区域化疗。
DOI:10.1002/anie.202116807
发表时间:2022-02-03
期刊:ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子:16.6
作者:Liu, Lingyan;Liu, Feiyang;Yi, Tao
通讯作者:Yi, Tao
原位示踪型一氧化氮控释体系的构建
  • 批准号:
    22377010
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    魏鹏
  • 依托单位:
国内基金
海外基金